Pfizer COVID-19 Vaccine 97 Percent Effective Against Symptomatic Disease
Analysis of data from Israel's vaccination campaign also showed vaccine to be 94 percent effective against asymptomatic disease
Women Show Faster Cognitive Decline Than Men
Declines in global cognition and executive function significantly faster for women, despite higher baseline performance
Patient-Provider Gender Concordance Affects Patient Heart Outcomes
American College of Cardiology workgroup recommends improving gender diversity in the workforce, research, and medical education
Early Immunologic Biomarker Predicts Renal Allograft Outcomes
Ratio of IL-10/TNFα produced by T1B three months after renal transplantation predicts clinical, subclinical rejection during first year
Immune Response Strong After One Dose in COVID-19-Seropositive Vaccinees
Vaccinees with preexisting immunity have antibody titers 10 to 45 times higher than those without preexisting immunity
ASA: Adding Icosapent Ethyl to Statin Further Cuts Stroke Risk
Event rates for time to first fatal or nonfatal stroke significantly reduced for IPE versus placebo
One Year Into Pandemic, Biden Promises Vaccines for All U.S. Adults by May 1
Remarks came on the one-year anniversary of the WHO declaring COVID-19 to be a pandemic
Teplizumab Could Delay Diagnosis of Type 1 Diabetes
Teplizumab improves beta-cell function in high-risk individuals with relatives who have type 1 diabetes
Guidelines Provided for Unilateral Lymphadenopathy After COVID-19 Vaccination
In most clinical settings, ipsilateral UAL after recent COVID-19 vaccination is benign finding; clinical follow-up recommended
Prevalence of Vascular Risk Factors High for Hispanics/Latinos
Despite high awareness, secondary stroke prevention strategies are low
